Retatrutide (R3-40)

Triple agonist: GLP-1 + GIP + Glucagon. Strength: 40 mg pen | 10 mg vial Contraindications: MTC/MEN2, pancreatitis, hepatic impairment; limited long-term data. Side effects: Nausea, vomiting, diarrhea, reduced appetite, potential HR elevation.

Sold by Wellness Tech Bio Distribution